PlaqueTec Establishes New Science Base at the Babraham Research Campus

PlaqueTec Ltd. has relocated its existing coronary plasma bank from Royal Papworth Hospital to the communal laboratory facility within the Babraham Research Campus in Cambridge. The company has also expanded its headquarters and device development facilities, which are now located in Cambourne Business Park, also in Cambridge.PlaqueTec is leading biomarker-based cardiovascular disease (CVD) research and is building a large database of CVD biology to transform care of people with coronary artery disease. The company was originally established 10 years ago within the Royal Papworth Hospital’s Cardiothoracic Bioincubator facility, which will soon relocate to the Cambridge Biomedical Campus.“We are so grateful for the past decade at Papworth, where we were able to develop our unique catheter device in close cooperation with world leading interventional cardiologists,” said Annalisa Jenkins, MBBS, FRCP, PlaqueTec CEO. “These moves all come at the perfect time as the communal facility at the Babraham Research Campus will help us expedite development of our CVD biomarker database and drive a new era of personalised medicine for people at high risk of heart attack.”